The BioBreak is an independent newsletter focusing on biotechnology stocks.
Our newsletter is posted online each month for immediate viewing by all subscribers.
Subscribe Now!

Member Login
Member ID
Password


 

Forgot Password?
Why Biotech Now?

Health care spending hit $1.7 trillion in 2003 and is set to double in 10 years. Prescription drug sales are expected to lead the growth in spending.

Baby boomer demographics favor innovative drug developers focused on large unmet medical needs.

The biotech pipeline is full with over 350 new drug candidates in late-stage human trials.

Click on the Our Approach link to further understand how The BioBreak can assist in your investment success.

  
 

The BioBreak Executive Summary
For Month Ending March 31, 2008
Indexes
March 2008
YTD 2008
Since 1/2/03
  • The BioBreak Portfolio
    • 4.11%
    -11.06%
    113.78%
  • Bio Tech Index $BTK
    • 2.14%
    -6.24%
    118.03%
  • Nasdaq BioTech Index
    • -0.40%
    -6.47%
    57.17%
  • Nasdaq
    • 1.40%
    -13.16%
    72.47%
  • Dow Jones
    • 0.93%
    -6.66%
    48.42%
  • S&P 500
    • 1.69%
    -7.72%
    53.79%
     
    Subscribe Now!
     

     

     
    As of April 11, 2008
    Inception Date
    1/2/2003
    Initial Investment
    $100,000
    Current Value
    $229,956
    Overall Performance +129.96%
    2008 Performance
    As of April 11, 2008
    BioBreak YTD
    -4.33%
    NASDAQ YTD
    -13.65%
    Dow Jones YTD
    -7.08%
    S&P 500 YTD
    -9.11%
    2007 Performance
    -18.34%
    2006 Performance
    -0.78%
    2005 Performance
    +8.96%
    2004 Performance
    +53.95%
    2003 Performance
    +76.85%

    Disclaimer

    Privacy Policy